Covid-19Is Novavax, the Latecomer Covid Vaccine, Worth the Wait?
Novavax's vaccine is based on proteins rather than mRNA and has been used since early 2022 in other countries.
Covid-19How Lawmakers in Texas and Florida Undermine COVID Vaccination Efforts
The shift in health information trails rhetoric from Republican politicians who have reversed their positions on COVID vaccines.
Covid-19Health Workers Warn Loosening Mask Advice in Hospitals Would Harm Patients and Providers
A CDC draft controversially concludes that N95 face masks are equivalent to looser, surgical face masks in certain settings.
Clinical CareExcessive Drinking During the Pandemic Increased CA's Alcoholic Liver Disease Death Rates
The rate peaked at 13.2 deaths per 100,000 residents in 2021, nearly double the rate from two decades ago.
Supply ChainU.S. Senate Bill Tackles Medical Supply Chain Weaknesses
The legislation gives the executive enhanced powers to cut red tape and reduce trade barriers with 'trusted allies.'
PharmaIndivior, 42 AGs Reach $102M Suboxone Antitrust Settlement
The AGs had claimed that Invidior used 'product hopping' to block competition from generics for its opioid treatment drug.
Covid-19End of COVID Emergency Will Usher in Changes Across the US Health System
As the government prepares to reverse some steps taken during the PHE, here's a glimpse at ways patients will be...
PharmaA Technicality Could Keep RSV Shots From Kids in Need
The CDC is now assessing whether nirsevimab would be eligible for the Vaccines for Children program.
Post-AcuteNursing Home Owners Drained Cash During Pandemic While Residents Deteriorated
Some nursing home owners moved money from their facilities through corporate arrangements that are widespread, and legal, in every state.
Covid-19FDA Experts Are Still Puzzled Over Who Should Get Which COVID Shots and When
Panel disagrees with FDA proposal that everyone get at least one shot a year, saying more information is needed.
PharmaWhat Older Americans Need to Know About Taking Paxlovid
Seek treatment with antiviral therapy, which remains effective against new COVID variants.
PharmaBernie Blasts 'Unacceptable Corporate Greed' As Moderna Mulls 4X Price Hike for COVID Vax
Quadrupling the price of COVID-19 vaccine would make it too expensive for millions of Americans, the Vermont Independent says.